other material
confidence high
sentiment neutral
materiality 0.65
Annovis Bio enters equity line with Keystone Capital for up to 2.05M shares
Annovis Bio, Inc.
- Company may sell up to 2,051,428 shares at market price, subject to 19.99% cap unless at-market.
- Initial commitment shares: 10,181 delivered at signing; additional shares on days 90 and 180.
- Proceeds will be used for working capital and general corporate purposes.
- Investor Keystone Capital cannot engage in short sales or hedging during agreement term.
- Fixed purchase limit: lower of 25,000 shares or $250,000; VWAP aggregate cap $10M.